Search Results - "Wish, Jay B."

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD by Gupta, Nupur, MD, Wish, Jay B., MD

“…Erythropoiesis-stimulating agents (ESAs) increase hemoglobin levels, reduce transfusion requirements, and have been the standard of treatment for anemia in…”
Get full text

Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation by Wish, Jay B

“…The increasing prevalence of multiple comorbidities among anemic patients with chronic kidney disease has made the use of serum ferritin and transferrin…”
Get full text

Kidney disease and congenital heart disease: Partnership for life by El Sayegh, Skye, Ephrem, Georges, Wish, Jay B., Moe, Sharon, Lim, Kenneth

“…The literature on the relationship between kidney and cardiovascular diseases is continuously expanding. Scientists have elucidated many of the neurohormonal…”
Get full text

Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged? by Wish, Jay B.

Get full text

Care Technician Staffing Ratios in Dialysis Units: In Search of a Balance Between Workforce and Patient Safety by Webb, Hanna, Wish, Jay B.

Get full text

Hemodialysis Vascular Access: A Historical Perspective on Access Promotion, Barriers, and Lessons for the Future by Besarab, Anatole, Frinak, Stanley, Margassery, Suresh, Wish, Jay B.

“…This review describes the history of vascular access for hemodialysis (HD) over the past 8 decades. Reliable, repeatable vascular access for outpatient HD…”
Get full text

Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus by Wish, Jay B, Pergola, Pablo

“…Chronic kidney disease (CKD) is one of the most frequent complications associated with type 2 diabetes mellitus (T2DM) and is also an independent risk factor…”
Get full text

Management of the Hemodialysis Unit: Core Curriculum 2016 by Blankschaen, Susan M., MBA, Saha, Sharmeela, MD, Wish, Jay B., MD

Get full text

Prevalence of Arteriovenous Fistulas in Incident Hemodialysis Patients: Correlation With Patient Factors That May Be Associated With Maturation Failure by Lilly, Michael P., MD, Lynch, Janet R., PhD, CPHQ, Wish, Jay B., MD, Huff, Edwin D., PhD, Chen, Shu-Cheng, MS, Armistead, Nancy C., MPA, McClellan, William M., MD

“…Background Lok et al previously reported a risk equation for arteriovenous fistula (AVF) maturation failure. It is unclear whether this model or a more…”
Get full text

Introduction of Biosimilar Therapeutics Into Nephrology Practice in the United States: Report of a Scientific Workshop Sponsored by the National Kidney Foundation by Wish, Jay B., MD, Charytan, Chaim, MD, Chertow, Glenn M., MD, Kalantar-Zadeh, Kamyar, MD, Kliger, Alan S., MD, Rubin, Robert J., MD, Yee, Jerry, MD, Fishbane, Steven, MD

“…Biosimilars are biologic medicines highly similar to the reference product with no meaningful clinical differences in terms of safety, purity, and potency. All…”
Get full text

Hemodialysis Access in Patients With Failed Kidney Transplants: Nephrologist, Heal Thyself by Khalil, Ali K., MD, Wish, Jay B., MD

Get full text

ESRD Networks: Past, Present, and Challenges for the Future by Wish, Jay B, Meyer, Klemens B

“…Established by Federal law in 1978, the ESRD Networks are regional nonprofit organizations that contract with the Centers for Medicare and Medicaid Services to…”
Get full text

Systemic Barriers to Optimal Hemodialysis Access by Donca, Ionel Z., MD, Wish, Jay B., MD

“…Summary Arteriovenous fistulas (AVFs) are considered the gold standard for hemodialysis vascular access based on their superior patency, low complication…”
Get full text

Are Consistency and Individualization Mutually Exclusive in Erythropoiesis-Stimulating Agent Therapy? by Wish, Jay B., MD

Get full text

Debate: Are Hydroxylase Inhibitors Stabilizers a Viable Alternative to Erythropoiesis-Stimulating Agents in the Management of Anemia in CKD? CON by Wish, Jay B

Get more information

Dialysis Technician Burnout: An Opportunity for Empowerment by Webb, Hanna, Wish, Jay B.

Get full text

Hemoglobin Variability as a Predictor of Mortality: What's a Practitioner to Do? by Wish, Jay B., MD

Get full text

Strategies to Reduce Rehospitalization in Patients with CKD and Kidney Failure by Doshi, Simit, Wish, Jay B

“…Readmissions in patients with nondialysis-dependent CKD and kidney failure are common and are associated with significant morbidity, mortality, and economic…”
Get full text

Recent and Emerging Therapies for Iron Deficiency in Anemia of CKD: A Review by Bazeley, Jonathan W., Wish, Jay B.

“…Iron deficiency commonly contributes to the anemia affecting individuals with chronic kidney disease. This review describes diagnostic criteria for iron…”
Get full text

Biosimilars-Emerging Role in Nephrology by Wish, Jay B

“…The Food and Drug Administration (FDA) defines a "biosimilar" agent as a biologic that is highly similar to the reference or originator biologic product…”
Get full text